Delivery Order SPE2DB20D3103-SPE2DB25FP4Z3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets (500-count) with a contract ceiling value of $1,396.35. This competitively awarded, firm fixed-price delivery order was executed on April 24, 2025, with an ultimate completion date of April 25, 2025. The contract involves no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 14, 2025, for Cetirizine HCL 10 mg tablets (100-count) with a ceiling value of $1,088.45. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,165.37 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages). The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was not set aside for any specific business category and was competitively awarded. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $1,770.43 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100-count units) on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,119.97 to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets (100-count) on September 4, 2025, with completion scheduled for September 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.65 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100-count packages) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and represents a continuation of the contractor's role as a critical pharmaceutical supplier to federal healthcare systems. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $5,680.22 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100 count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This delivery order is structured as a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $8,787 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award from the agency's Medical Supply Chain operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Cetirizine HCL 10 mg tablets in quantities of 500 units. This firm fixed-price delivery order, valued at $2,119.84, represents a non-competitive set-aside award and carries a completion deadline of August 22, 2025. The pharmaceutical products will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages) with a ceiling value of $7,861.18. This firm fixed price delivery order, with an ultimate completion date of September 17, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was awarded on a competitive basis with no set-aside designation and will be performed at...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP4Z3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,354.67 to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets (500-count supply) on July 14, 2025, with an ultimate completion date of July 15, 2025. This contract was awarded on a non-competitive, firm fixed-price basis under a delivery order structure and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a competitively awarded delivery order, this award represents a routine fulfillment of pharmaceutical supply needs through the federal medical procurement system. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company's substantial IDC with DLA enables it to supply a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and other government healthcare systems. This specific order for Cetirizine HCL tablets demonstrates the company's ongoing role in fulfilling routine pharmaceutical supply requirements for the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/14/25 |